Back
ESC Premium Access

Risk for adverse outcome events according to paroxysmal vs. non-paroxysmal atrial fibrillation

Session: Poster session 5 - Demographics and screening
Topic: Atrial fibrillation (AF)
Speaker: Doctor S. Blum (Basel, CH)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Steffen Blum

University Hospital Basel, Basel (Switzerland)
0 follower

11 more presentations in this session

Screening for atrial fibrillation in the primary health care setting

Speaker: Doctor F. Ghazal (Stockholm, SE)

Access
Abstract
Slides
Like
Thumbnail

How patient advocacy in partnership with community pharmacy can identify people at risk of AF in community pharmacy setting

Speaker: Mrs T. Lobban (Oxford, GB)

Access
Abstract
Slides
Like
Thumbnail

Benefits of active involvement of community pharmacists in know your pulse awareness campaign

Speaker: Doctor S. Antoniou (London, GB)

Access
Abstract
Slides
Like
Thumbnail

lipid profile and incidence of atrial fibrillation: results from the Kailuan Study

Speaker: Doctor Y. Xia (Dalian, CN)

Access
Abstract
Like
Thumbnail

Prevalence rates of atrial fibrillation tentatively increased during and after the Great East Japan earthquake.

Speaker: Doctor K. Tamaki (Morioka, JP)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 5 - Demographics and screening

Speakers: Doctor S. Blum, Doctor F. Ghazal, Mrs T. Lobban, Doctor S. Antoniou, Doctor Y. Xia...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources